Business
PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024
All figures in Canadian dollars ($) unless otherwise specified Toronto, Ontario and Rionegro, C...
About this update from Pharmacielo Ltd.
[{"type":"text","content":"PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - October 7, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) (\"PharmaCielo\" or the \"Company\"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today made two corporate announcements. Appointment of Davidson & Company as Auditor The Board of Directors has received the resignation of BDO Canada LLP (\"BDO\") as independent registered auditor of the Company on September 16, 2024, and has appointed Davidson & Company LLP (\"Davidson\") as the new independent registered auditor of PharmaCielo, effective October 7, 2024, until the close of the Company's next Annual General Meeting. Additional capabilities and regional experience of Davidson and its international affiliate Nexia International in Colombia will provide PharmaCielo with enhanced audit committee oversight.There were no reservations in BDO's audit reports for any financial period during which BDO was the Company's auditor. There are no \"reportable events\" (as the term is defined in National Instrument 51-102 - Continuous Disclosure Obligations) between the Company and BDO. In accordance with National Instrument 51-102, the Notice of Change of Auditor, together with the required letters from BDO and Davidson, have been reviewed by the Company's Audit Committee and have been filed on SEDAR+.Change to Financial Year-End PharmaCielo today also announced that the Company will change its financial year end from December 31 to March 31 (\"Change in Year End\") to better align with the reporting cycle of its peers. The Company will file a transitional period report that will provide audited financial statements for the fifteen-month period from January 1, 2024, to March 31, 2025. The Company's next financial year will cover the period from April 1, 2024, to March 31, 2025. About PharmaCieloPharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) is a global company, headquartered in Canada, with a focus on ethical and sustainable cultivating, processing and supply of all natural, pharmaceutical-grade medical dried c...